UH
DGX icon

Unigestion Holding’s Quest Diagnostics DGX Stock Holding History

Unigestion Holding’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,499
Closed -$1.3M – 162
2023
Q3 		$1.3M Hold
10,499
– – 0.08% 101
2023
Q2 		$1.48M Hold
10,499
– – 0.09% 110
2023
Q1 		$1.46M Hold
10,499
– – 0.08% 123
2022
Q4 		$1.65M Buy
+10,499
New +$1.51M 0.09% 121

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Unigestion Holding's DGX Position: Q4 2023 in Review

Unigestion Holding sold out of Quest Diagnostics (DGX) in Q4 2023, closing a stake of 10,499 shares — an estimated $1.3M sold.

Unigestion Holding first reported a position in DGX in Q4 2022 and held it in 4 quarters. The position peaked at $1.65M in Q4 2022. 827 funds tracked by Wall St. Rank hold DGX as of Q4 2023.

  • Unigestion Holding reported no remaining Quest Diagnostics position as of Q4 2023 after selling out during the quarter.
  • Unigestion Holding sold 10,499 Quest Diagnostics shares in Q4 2023, an estimated $1.3M.
  • Unigestion Holding first reported a position in Quest Diagnostics in Q4 2022 and held it in 4 quarters.
  • Unigestion Holding's Quest Diagnostics position peaked at $1.65M in Q4 2022.
  • 827 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2023.

Based on Unigestion Holding's 13F filing for Q4 2023, filed 14 Feb 2024.